Abstract
© 2016, American Society for Microbiology.Loss of pancreatic β-cell maturity occurs in diabetes and insulinomas. Although both physiological and pathological stresses are known to promote β-cell dedifferentiation, little is known about the molecules involved in this process. Here we demonstrate that activinB, a transforming growth factor β (TGF-β)-related ligand, is upregulated during tumorigenesis and drives the loss of insulin expression and β-cell maturity in a mouse insulinoma model. Our data further identify Pax4 as a previously unknown activinB target and potent contributor to the observed β-cell dedifferentiation. More importantly, using compound mutant mice, we found that deleting activinB expression abolishes tumor β-cell dedifferentiation and, surprisingly, increases survival without significantly affecting tumor growth. Hence, this work reveals an unexpected role for activinB in the loss of β-cell maturity, islet plasticity, and progression of insulinoma through its participation in β-cell dedifferentiation.
Cite
CITATION STYLE
Ripoche, D., Charbord, J., Hennino, A., Teinturier, R., Bonnavion, R., Jaafar, R., … Bertolino, P. (2016). ActivinB Is Induced in Insulinoma To Promote Tumor Plasticity through a β-Cell-Induced Dedifferentiation. Molecular and Cellular Biology, 36(5), 756–764. https://doi.org/10.1128/mcb.00930-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.